EGFR and non-small cell lung carcinoma: Similarly, on the EGFR mutation front, Wu et al. used contrast-enhanced chest CT to build radiomic models predicting EGFR mutation status in NSCLC, reporting AUCs in the range ~0.80–0.90 in multi-institution cohorts80.